IRIS
MONACO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.782
NA - Nord America 1.779
AS - Asia 455
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 4.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.772
IE - Irlanda 700
DE - Germania 315
UA - Ucraina 282
SE - Svezia 198
FI - Finlandia 195
CN - Cina 182
HK - Hong Kong 135
SG - Singapore 107
IT - Italia 29
IN - India 25
CZ - Repubblica Ceca 16
BE - Belgio 13
GB - Regno Unito 13
FR - Francia 8
CA - Canada 7
GR - Grecia 5
IR - Iran 4
LT - Lituania 3
EU - Europa 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
ES - Italia 1
IL - Israele 1
MA - Marocco 1
NO - Norvegia 1
RO - Romania 1
Totale 4.019
Salva come PNG Salva come JPEG
Città #
Dublin 700
Jacksonville 526
Dearborn 292
Hong Kong 132
Wilmington 123
Chandler 112
Lawrence 95
Princeton 95
San Mateo 76
Ann Arbor 74
Beijing 74
Singapore 65
Andover 63
Ashburn 35
Hefei 17
Brno 16
Kunming 16
Woodbridge 16
Piemonte 15
Norwalk 14
Brussels 13
Monmouth Junction 13
Nanjing 13
Helsinki 12
Düsseldorf 9
Munich 9
Fairfield 8
Santa Clara 8
Boardman 7
Hebei 7
Toronto 7
Bremen 6
Houston 6
Shenyang 6
Fuzhou 5
Ardabil 4
Guangzhou 4
Milan 4
Quzhou 4
Jinan 3
Jinhua 3
Leawood 3
Nanchang 3
San Diego 3
Berlin 2
Cameri 2
Hangzhou 2
Philadelphia 2
Seattle 2
Shaoxing 2
Torino 2
Zhengzhou 2
Auburn Hills 1
Augusta 1
Bolzano 1
Cambridge 1
Changsha 1
Chengdu 1
Chicago 1
Chongqing 1
Clearwater 1
Coeur D Alene 1
Grafenhausen 1
Grafing 1
Gunzenhausen 1
Huzhou 1
Lishui 1
London 1
Los Angeles 1
Messina 1
Nanning 1
Ningbo 1
Novara 1
Pieve Emanuele 1
Redwood City 1
Reghin 1
Shanghai 1
Taizhou 1
Tel Aviv 1
Wenzhou 1
Wuhan 1
Xian 1
Zanesville 1
Zhongxin 1
Totale 2.764
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-risperidone interactions in patients with epilepsy 81
Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) 75
Cerebrospinal fluid levels of tissue inhibitor of metalloproteinase 1 are increased in subjects with mild cognitive impairment 65
Association of haplotype combination of serotonin transporter gene polymorphisms with monthly headache days in MOH patients 64
Posttraumatic epilepsy: neuroradiologic and neuropsychological assessment of long-term outcome 63
ICOS gene haplotypes correlate with multiple sclerosis development and progression 62
Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP 61
Abnormal response to glutamate of T lymphocytes from multiple sclerosis patients 61
A91V variation of the perforin gene in patients with multiple sclerosis 59
Anger symptoms and "delinquent" behavior in Tourette syndrome with and without attention deficit hyperactivity disorder 59
IP-10 haplotypes and multiple sclerosis: association and correlation with clinical course 58
Antiepileptic-antipsychotic drug interactions:a critical review of the evidence 57
Antiepileptic drug-induced mania in patients with epilepsy: what do we know? 57
Accuracy of the ICD-9 codes for identifying TIA and stroke in an Italian automated database 55
Role of 2 Common Variants of 5HT2A Gene in Medication Overuse Headache 55
Applications of transcranial magnetic stimulation in sleep medicine 55
Chronic alcohol use and first symptomatic epileptic seizures 55
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 55
Complex movement disorders in primary antiphospholipid syndrome: a case report 54
Anticonvulsant Drugs and Cognitive Functions in Elderly Patients with Epilepsy 53
Defective T cell Fas function in patients with multiple sclerosis 53
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers 52
Cerebral venous thrombosis: a retrospective multicentre study of 48 patients 52
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 52
Antiepileptic drugs and psychopathology of epilepsy: an update 51
Can patients with epilepsy predict their seizures? 48
Variations of the perforin gene in patients with multiple sclerosis 48
Signals of Apoptotic Pathways in Several Types of Meningioma 48
HLA-class I markers and multiple sclerosis susceptibility in the Italian population 47
Brain mechanisms underlying the placebo effect in neurological disorders 47
Complex pattern of convulsive syncope in glossopharyngeal neuralgia: video/EEG report and short review 46
Osteopontin gene variations protect against multiple sclerosis development and evolution 45
Clinical correlates of pathological gambling symptoms in patients with epilepsy 45
Myeloneuropathy due to copper deficiency: clinical and MRI findings after copper supplementation 44
Current practices in the management of pulmonary Groun-Glass Opacities: a survey of SICT members 44
Churg-Strauss syndrome associated with the leukotriene antagonist montelukast 43
Brain mechanisms of altered conscious states during epileptic seizures 43
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline 43
Generalized peripheral nerve hyperexcitability associated with lithium 42
The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients 42
Levodopa-induced belly dancer's dyskinesias in Parkinson's disease: report of one case 41
ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution 41
The "bicameral mind" 30 years on: a critical reappraisal of Julian Jaynes' hypothesis 41
Measuring the level and content of consciousness during epileptic seizures: the Ictal Consciousness Inventory 40
Manic/hypomanic symptoms and quality of life measures in patients with epilepsy 40
Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy 39
Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study 39
Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial 39
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males 38
Progranulin gene mutation scanning in multiple sclerosis patients with cognitive impairment 38
On the prevalence of bipolar disorder in epilepsy 38
Obsessionality, obsessive-compulsive disorder, and temporal lobe epilepsy 38
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis 38
SLE-related longitudinal myelitis with favorable outcome 37
Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy 37
E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis 37
Excitability of the human epileptic cortex after chronic valproate: a reappraisal 37
Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy 37
CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course 37
Progression of MRI abnormalities in herpes simplex encephalitis despite clinical improvement: natural history or disease progression? 36
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 36
Influence of the novel M62I polymorphism in PSGL-1 gene on susceptibility and progression of multiple sclerosis 36
Cortical inhibition in Parkinson's disease: new insights from early, untreated patients 36
Diagnosis of psychogenic paralysis: the role of motor evoked potentials 36
Moyamoya disease and arteriovenous fistula of the epiaortic vessels 36
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trial 36
Motor cortical organization in an adult with hemimegalencephaly and late onset epilepsy 36
Serotonin syndrome associated with tramadol-sertraline coadministration 35
The neural correlates of impaired consciousness in coma and unresponsive states 35
Cluster-like headache and idiopathic intracranial hypertension: a case report 35
Ketogenic diet: electrophysiological effects on the normal human cortex 35
GSK3β genetic variability in patients with Multiple Sclerosis 34
Use of psychotropic drugs in patients with epilepsy: interactions and seizure risk 34
The role of aura in psychopathology and dissociative experiences in epilepsy 34
Consciousness, epilepsy, and emotional qualia 34
Spontaneous intracranial hypotension presenting as a reversible dorsal midbrain syndrome 34
The structured assessment of depression in brain-damaged individuals: translation and validation study of the Italian version 34
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 34
Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease 34
Cortical excitability in drug-naive patients with partial epilepsy: a cross-sectional study 34
Stem cells in amyotrophic lateral sclerosis: state of the art 34
Famous people with Gilles de la Tourette syndrome? 33
Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis 33
MDC/CCL22 intrathecal levels in patients with multiple sclerosis 33
Persistent akinetic mutism after bilateral paramedian thalamic infarction 32
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis 32
Epilepsy and bipolar disorders 32
Health-related quality of life measures and psychiatric comorbidity in patients with migraine 32
Phenomenology of obsessive compulsive disorder in patients with temporal lobe epilepsy or tourette syndrome 32
Illness perceptions, mood and health-related quality of life in patients with amyotrophic lateral sclerosis 32
The behavioral spectrum of Gilles de la Tourette syndrome 31
Neurological picture. Putamen hyperperfusion in subcortical-supraspinal myoclonus 31
Risk and resilience factors for specific and general psychopathology worsening in people with Eating Disorders during COVID-19 pandemic: a retrospective Italian multicentre study 30
MDC/CCL22 intrathecal levels in patients with multiple sclerosis 28
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma 27
Totale 4.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020731 0 0 0 0 0 185 229 50 108 50 106 3
2020/2021560 98 1 94 3 61 4 97 0 95 5 99 3
2021/2022516 30 4 87 40 12 1 65 10 47 13 79 128
2022/20231.142 102 44 55 16 44 87 18 46 688 5 22 15
2023/2024343 13 13 19 5 54 0 132 12 0 0 37 58
2024/202578 25 3 38 3 6 3 0 0 0 0 0 0
Totale 4.077